# Efficacy of Targeted Drugs Combined With Chemotherapy in the Treatment of T-ALL

> **NCT07203352** · PHASE3 · RECRUITING · sponsor: **Nanfang Hospital, Southern Medical University** · enrollment: 154 (estimated)

## Conditions studied

- Acute Lymphoblastic Leukemia

## Interventions

- **DRUG:** targeted drug

## Key facts

- **NCT ID:** NCT07203352
- **Lead sponsor:** Nanfang Hospital, Southern Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-10-01
- **Primary completion:** 2026-12-01
- **Final completion:** 2026-12-30
- **Target enrollment:** 154 (ESTIMATED)
- **Last updated:** 2025-10-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07203352

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07203352, "Efficacy of Targeted Drugs Combined With Chemotherapy in the Treatment of T-ALL". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07203352. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*